Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth
Enrique Martin-Gayo, Jacqueline Cronin, Taylor Hickman, Zhengyu Ouyang, Madelene Lindqvist, Kellie E. Kolb, Julian Schulze zur Wiesch, Rafael Cubas, Filippos Porichis, Alex K. Shalek, Jan van Lunzen, Elias K. Haddad, Bruce D. Walker, Daniel E. Kaufmann, Mathias Lichterfeld, Xu G. Yu
Enrique Martin-Gayo, Jacqueline Cronin, Taylor Hickman, Zhengyu Ouyang, Madelene Lindqvist, Kellie E. Kolb, Julian Schulze zur Wiesch, Rafael Cubas, Filippos Porichis, Alex K. Shalek, Jan van Lunzen, Elias K. Haddad, Bruce D. Walker, Daniel E. Kaufmann, Mathias Lichterfeld, Xu G. Yu
View: Text | PDF
Research Article AIDS/HIV

Circulating CXCR5+CXCR3+PD-1lo Tfh-like cells in HIV-1 controllers with neutralizing antibody breadth

  • Text
  • PDF
Abstract

HIV-1–specific broadly neutralizing antibodies (bnAbs) typically develop in individuals with continuous high-level viral replication and increased immune activation, conditions that cannot be reproduced during prophylactic immunization. Understanding mechanisms supporting bnAb development in the absence of high-level viremia may be important for designing bnAb-inducing immunogens. Here, we show that the breadth of neutralizing antibody responses in HIV-1 controllers was associated with a relative enrichment of circulating CXCR5+CXCR3+PD-1lo CD4+ T cells. These CXCR3+PD-1lo Tfh-like cells were preferentially induced in vitro by functionally superior dendritic cells from controller neutralizers, and able to secrete IL-21 and support B cells. In addition, these CXCR3+PD-1lo Tfh-like cells contained higher proportions of stem cell–like memory T cells, and upon antigenic stimulation differentiated into PD-1hi Tfh-like cells in a Notch-dependent manner. Together, these data suggest that CXCR5+CXCR3+PD-1lo cells represent a dendritic cell–primed precursor cell population for PD-1hi Tfh-like cells that may contribute to the generation of bnAbs in the absence of high-level viremia.

Authors

Enrique Martin-Gayo, Jacqueline Cronin, Taylor Hickman, Zhengyu Ouyang, Madelene Lindqvist, Kellie E. Kolb, Julian Schulze zur Wiesch, Rafael Cubas, Filippos Porichis, Alex K. Shalek, Jan van Lunzen, Elias K. Haddad, Bruce D. Walker, Daniel E. Kaufmann, Mathias Lichterfeld, Xu G. Yu

×

Figure 6

CXCR3+PD-1lo pTfh cells can differentiate into PD-1hi cells in a Notch-dependent fashion.

Options: View larger image (or click on image) Download as PowerPoint
CXCR3+PD-1lo pTfh cells can differentiate into PD-1hi cells in a Notch-d...
(A) Sorted CXCR5+CXCR3+PD-1lo Tfh-like cells were cultured with autologous B cells and SEB for 6 days (left plot). PD-1lo and PD-1hi events from these cultures were selectively resorted and cocultured for 6 additional days with B cells and SEB. Right plots show PD-1 expression on resorted PD-1lo and PD-1hi cells after the second 6-day culture assay. Dot plots from a representative experiment are shown. Numbers on the gates represent the proportion of cells. (B) Proportions of remaining PD-1lo and PD-1hi cells detected on day 6 of coculture of freshly sorted (F) or resorted (R) CXCR5+CXCR3+PD-1lo (n = 5), CXCR5+CXCR3+PD-1hi (n = 5), and CXCR5+CXCR3–PD-1hi (n = 5) pTfh cells with total B cells and SEB. Statistical significance was calculated using a Friedman test followed by Dunn’s test (*P < 0.05; **P < 0.01). (C) Mean fluorescence intensity of Notch 1, 2, and 4 and intracellular Notch (ICN) in pTfh subsets and total CD4+ T cells (n = 8). Statistical significance was calculated using a Friedman test followed by a Dunn’s test (*P < 0.05; **P < 0.01; *** P < 0.01). (D) Proportions of PD-1lo or PD-1hi Tfh-like cells generated upon coculture of naive CD4+ T cells with autologous B cells and allogeneic mDCs in the presence of gamma secretase inhibitors (GSI) in comparison to 100 nM DMSO (n = 6). Statistical significance was calculated using a 2-tailed Wilcoxon matched-pairs signed-rank test (*P < 0.05). (E) Proportions of PD-1hi T cells derived from CXCR5+CXCR3+PD-1lo CD4+ T cells after 6 days of coculture with autologous B cells and SEB in the presence of GSI compared with DMSO (n = 6). Statistical significance was calculated using a two-tailed Wilcoxon matched-pairs signed-rank test (*P < 0.05).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts